Ben Price

Dr. Ben G.
Price, MD, is an Independent Non-Executive Director at Percheron Therapeutics Ltd. He is on the Board of Directors at Percheron Therapeutics Ltd. and AssayQuant Technologies, Inc. Dr. Price was previously employed as a President, Chief Executive & Medical Officer by NeuroBo Pharmaceuticals, Inc., a Chief Medical Officer by KCBN Holding, Inc., an Independent Director by Sarepta Therapeutics, Inc., a Chief Executive & Medical Officer by Drug Safety Solutions LLC, a Clinical Development Director-Oncology by MedImmune LLC, a Member by Academy of Physicians In Clinical Research, a Member by American Medical Association, and a Member by American Society for Microbiology.
He also served on the board at Rexahn Pharmaceuticals, Inc. He received his undergraduate degree from the University of Rio Grande, a graduate degree from the University of Santiago de Compostela and a doctorate degree from the University of Santiago de Compostela.